S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TLSA Tiziana Life Sciences Ltd

0.6953

-0.0347 (-4.75%)

Pre Market

Last Updated: 01:17:19

Delayed by 15 minutes

This Biotech Found Significant Success Following Key Announcement

A New York-based biotech company is stealing the mid-week show after it announced the broadening of its Phase 2 clinical trial for non-active secondary progressive multiple...

To read the full story on AllPennyStocks.com, click here.

Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Tiziana Life Sciences Charts.

Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Tiziana Life Sciences Charts.

Tiziana Life Sciences Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
Tuesday 17 December 2024 (3 weeks ago) • GlobeNewswire Inc.

This Biotech Found Significant Success Following Key Announcement
Thursday 5 December 2024 (1 month ago) • AllPennyStocks.com

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 4 December 2024 (1 month ago) • Edgar (US Regulatory)

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
Wednesday 4 December 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 19 November 2024 (2 months ago) • Edgar (US Regulatory)

Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
Tuesday 19 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 2 November 2024 (2 months ago) • Edgar (US Regulatory)

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
Saturday 2 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 1 November 2024 (2 months ago) • Edgar (US Regulatory)

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
Thursday 31 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 30 October 2024 (2 months ago) • Edgar (US Regulatory)

More Tiziana Life Sciences Ltd News Articles

Westpac Banking

Verizon Communications

Australia And New Zealan...

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions